Literature DB >> 21235577

Decreased activity of the 20S proteasome in the brain white matter and gray matter of patients with multiple sclerosis.

Jianzheng Zheng1, Oscar A Bizzozero.   

Abstract

Carbonylated (oxidized) proteins are known to accumulate in the cerebral white matter (WM) and gray matter (GM) of patients with multiple sclerosis (MS). Although oxidative stress is necessary for carbonyl generation, it is the failure of the degradation systems that ultimately leads to the build-up of carbonylated proteins within tissues. In this study, we measured the activity of the 20S proteasome and other proteolytic systems in the cerebral WM and GM of 13 MS patients and 13 controls. We report that the activities of the three peptidases of the 20S proteasome (i.e. chymotrypsin-like, caspase-like and trypsin-like) in both MS-WM and MS-GM are greatly reduced. Interestingly, neither the amount of proteasome nor the levels of the catalytic subunits (β1, β2, and β5) are diminished in this disease. Proteins containing Lys-48 poly-ubiquitin also accumulate in MS tissues, indicating failure of the 26S proteasome as well. Levels of the regulatory caps 11S α and 19S are also lower in MS than in controls, suggesting that the activity of the more complex proteasomes may be reduced further. Finally, the activities of other proteases that might also remove oxidized proteins (calpain, cathepsin B, mitochondrial LonP) are not lessened in MS. Together, these studies suggest that direct inactivation of proteolytic centers in the 20S particle and/or the presence of specific inhibitors is the underlying cause of proteasomal dysfunction in MS.
© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21235577      PMCID: PMC3055957          DOI: 10.1111/j.1471-4159.2011.07182.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  51 in total

Review 1.  Regulatory subunit interactions of the 26S proteasome, a complex problem.

Authors:  K Ferrell; C R Wilkinson; W Dubiel; C Gordon
Journal:  Trends Biochem Sci       Date:  2000-02       Impact factor: 13.807

Review 2.  Age-related changes in protein oxidation and proteolysis in mammalian cells.

Authors:  T Grune; R Shringarpure; N Sitte; K Davies
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-11       Impact factor: 6.053

3.  Assessment of proteasome activity in cell lysates and tissue homogenates using peptide substrates.

Authors:  Kenneth J Rodgers; Roger T Dean
Journal:  Int J Biochem Cell Biol       Date:  2003-05       Impact factor: 5.085

Review 4.  Oxidized proteins: mechanisms of removal and consequences of accumulation.

Authors:  Rachael A Dunlop; Ulf T Brunk; Kenneth J Rodgers
Journal:  IUBMB Life       Date:  2009-05       Impact factor: 3.885

Review 5.  Oxidized mitochondrial protein degradation and repair in aging and oxidative stress.

Authors:  Nicolas Ugarte; Isabelle Petropoulos; Bertrand Friguet
Journal:  Antioxid Redox Signal       Date:  2010-08-15       Impact factor: 8.401

6.  Proteasome inhibition in neuronal cells induces a proinflammatory response manifested by upregulation of cyclooxygenase-2, its accumulation as ubiquitin conjugates, and production of the prostaglandin PGE(2).

Authors:  P Rockwell; H Yuan; R Magnusson; M E Figueiredo-Pereira
Journal:  Arch Biochem Biophys       Date:  2000-02-15       Impact factor: 4.013

7.  Impaired proteasome function in Alzheimer's disease.

Authors:  J N Keller; K B Hanni; W R Markesbery
Journal:  J Neurochem       Date:  2000-07       Impact factor: 5.372

8.  Grey matter abnormalities in multiple sclerosis: proton magnetic resonance spectroscopic imaging.

Authors:  R Sharma; P A Narayana; J S Wolinsky
Journal:  Mult Scler       Date:  2001-08       Impact factor: 6.312

9.  Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts.

Authors:  N Sitte; M Huber; T Grune; A Ladhoff; W D Doecke; T Von Zglinicki; K J Davies
Journal:  FASEB J       Date:  2000-08       Impact factor: 5.191

10.  Reduced proteasomal activity contributes to the accumulation of carbonylated proteins in chronic experimental autoimmune encephalomyelitis.

Authors:  Jianzheng Zheng; Oscar A Bizzozero
Journal:  J Neurochem       Date:  2010-11-19       Impact factor: 5.372

View more
  13 in total

1.  Decreased levels of constitutive proteasomes in experimental autoimmune encephalomyelitis may be caused by a combination of subunit displacement and reduced Nfe2l1 expression.

Authors:  Kara L Shanley; Che-Lin Hu; Oscar A Bizzozero
Journal:  J Neurochem       Date:  2019-12-02       Impact factor: 5.372

2.  Ganglion cell loss in relation to visual disability in multiple sclerosis.

Authors:  Scott D Walter; Hiroshi Ishikawa; Kristin M Galetta; Reiko E Sakai; Daniel J Feller; Sam B Henderson; James A Wilson; Maureen G Maguire; Steven L Galetta; Elliot Frohman; Peter A Calabresi; Joel S Schuman; Laura J Balcer
Journal:  Ophthalmology       Date:  2012-02-23       Impact factor: 12.079

3.  Effects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis.

Authors:  Nicole Trager; Amena Smith; Gerald Wallace Iv; Mitsuyoshi Azuma; Jun Inoue; Craig Beeson; Azizul Haque; Naren L Banik
Journal:  J Neurochem       Date:  2014-02-12       Impact factor: 5.372

4.  The role of PSMB5 in sodium arsenite-induced oxidative stress in L-02 cells.

Authors:  Ying Lv; Qian Hu; Mingyang Shi; Wen Wang; Yuancui Zheng; Zhong Yang; Liuyu Peng; Dingnian Bi; Aihua Zhang; Yong Hu
Journal:  Cell Stress Chaperones       Date:  2020-04-16       Impact factor: 3.667

5.  Changes in 20S subunit composition are largely responsible for altered proteasomal activities in experimental autoimmune encephalomyelitis.

Authors:  Jianzheng Zheng; Anushka Dasgupta; Oscar A Bizzozero
Journal:  J Neurochem       Date:  2012-03-14       Impact factor: 5.372

Review 6.  Inhibitors of the immunoproteasome: current status and future directions.

Authors:  Zachary Miller; Lin Ao; Kyung Bo Kim; Wooin Lee
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

7.  NQO1 gene rs1800566 variant is not associated with risk for multiple sclerosis.

Authors:  José A G Agúndez; Elena García-Martín; Carmen Martínez; Julián Benito-León; Jorge Millán-Pascual; Patricia Calleja; María Díaz-Sánchez; Diana Pisa; Laura Turpín-Fenoll; Hortensia Alonso-Navarro; Lucía Ayuso-Peralta; Dolores Torrecillas; José Francisco Plaza-Nieto; Félix Javier Jiménez-Jiménez
Journal:  BMC Neurol       Date:  2014-04-23       Impact factor: 2.474

Review 8.  Detection of protein aggregates in brain and cerebrospinal fluid derived from multiple sclerosis patients.

Authors:  Monique Antoinette David; Mourad Tayebi
Journal:  Front Neurol       Date:  2014-12-02       Impact factor: 4.003

9.  Increased carbonylation, protein aggregation and apoptosis in the spinal cord of mice with experimental autoimmune encephalomyelitis.

Authors:  Anushka Dasgupta; Jianzheng Zheng; Nora I Perrone-Bizzozero; Oscar A Bizzozero
Journal:  ASN Neuro       Date:  2013       Impact factor: 4.146

Review 10.  Current understanding on the role of standard and immunoproteasomes in inflammatory/immunological pathways of multiple sclerosis.

Authors:  Elena Bellavista; Aurelia Santoro; Daniela Galimberti; Cristoforo Comi; Fabio Luciani; Michele Mishto
Journal:  Autoimmune Dis       Date:  2014-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.